D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 58 Citations 10,324 205 World Ranking 7322 National Ranking 2244

Overview

What is he best known for?

The fields of study he is best known for:

  • Organic chemistry
  • Enzyme
  • Amino acid

Pharmacology, Receptor, Stereochemistry, Biochemistry and Immune system are his primary areas of study. The various areas that Sander G. Mills examines in his Pharmacology study include Sphingosine-1-phosphate receptor, Asthma, Morpholine and Migraine. His Receptor research incorporates elements of Biological activity, Endocrinology and Trifluoromethyl.

Sander G. Mills interconnects Antagonist and Chemokine receptor, Chemokine receptor activity in the investigation of issues within Stereochemistry. His Immune system research includes themes of Tissue transplant and Bone marrow. As a part of the same scientific study, he usually deals with the Piperidine, concentrating on CCR5 receptor antagonist and frequently concerns with Chemical synthesis.

His most cited work include:

  • Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors (932 citations)
  • Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes (297 citations)
  • Morpholine and thiomorpholine tachykinin receptor antagonists (220 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Stereochemistry, Pharmacology, Receptor, Chemical synthesis and Tachykinin receptor. His Stereochemistry research is multidisciplinary, incorporating perspectives in Antagonist and CCR5 receptor antagonist, Chemokine receptor. Sander G. Mills has included themes like Asthma and Migraine in his Pharmacology study.

His Receptor research integrates issues from Endocrinology, Immune system and Bone marrow. His Chemical synthesis research incorporates themes from Selectivity, Structure–activity relationship, Moiety and Carboxamide. Sander G. Mills combines subjects such as Combinatorial chemistry, Morpholine, Active ingredient and Calcium channel with his study of Tachykinin receptor.

He most often published in these fields:

  • Stereochemistry (41.22%)
  • Pharmacology (28.57%)
  • Receptor (24.90%)

What were the highlights of his more recent work (between 2005-2016)?

  • Stereochemistry (41.22%)
  • Receptor (24.90%)
  • Chemical synthesis (19.18%)

In recent papers he was focusing on the following fields of study:

Sander G. Mills spends much of his time researching Stereochemistry, Receptor, Chemical synthesis, Pharmacology and Antagonist. His Stereochemistry study integrates concerns from other disciplines, such as CCR2, Structure–activity relationship and Trifluoromethyl. As part of his studies on Receptor, he often connects relevant subjects like Endocrinology.

His research in Chemical synthesis intersects with topics in Agonist, Biological activity, Selectivity and Cyclopentane. In his study, Active ingredient is strongly linked to Tachykinin receptor, which falls under the umbrella field of Pharmacology. His biological study spans a wide range of topics, including Reductase and Combination therapy.

Between 2005 and 2016, his most popular works were:

  • Selective Small-Molecule Agonists of G Protein–Coupled Receptor 40 Promote Glucose-Dependent Insulin Secretion and Reduce Blood Glucose in Mice (155 citations)
  • Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. (65 citations)
  • CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates (58 citations)

In his most recent research, the most cited papers focused on:

  • Organic chemistry
  • Enzyme
  • Amino acid

The scientist’s investigation covers issues in Stereochemistry, Agonist, Chemical synthesis, Receptor and CCR2. His Stereochemistry research is multidisciplinary, incorporating elements of Ether, Morpholine, Tertiary amine and NK1 receptor antagonist. The study incorporates disciplines such as Pharmacokinetics and Insulin in addition to Agonist.

His work deals with themes such as Selectivity, Transplantation and Sphingosine-1-phosphate receptor, which intersect with Chemical synthesis. The CCR2 study combines topics in areas such as CC chemokine receptors, Antagonist, Trifluoromethyl and Carboxamide. His biological study spans a wide range of topics, including Diabetes mellitus and Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors

Mark S. Kramer;Neal Cutler;John Feighner;Ram Shrivastava.
Science (1998)

1317 Citations

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M. Forrest;S.-Y. Sun;R. Hajdu;J. Bergstrom.
Journal of Pharmacology and Experimental Therapeutics (2004)

377 Citations

Chemistry of tricarbonyl hemiketals and application of Evans technology to the total synthesis of the immunosuppressant (-)-FK-506

Todd K. Jones;Robert A. Reamer;Richard Desmond;Sander G. Mills.
Journal of the American Chemical Society (1990)

264 Citations

Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

J. J. Hale;S. G. Mills;M. Maccoss;P. E. Finke.
Journal of Medicinal Chemistry (1998)

257 Citations

Src kinase inhibitor compounds

Julianne A. Hunt;Sander G. Mills;Peter J. Sinclair;Dennis M. Zaller.
(2000)

245 Citations

Morpholine and thiomorpholine tachykinin receptor antagonists

Conrad P. Dorn;Paul E. Finke;Jeffrey J. Hale;Malcolm MacCoss.
(1993)

233 Citations

Total synthesis of immunosuppressant (-)-FK-506

Todd K. Jones;S. G. Mills;R. A. Reamer;D. Askin.
Journal of the American Chemical Society (1989)

215 Citations

Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice.

Carina P. Tan;Yue Feng;Yun Ping Zhou;George J. Eiermann.
Diabetes (2008)

201 Citations

Pyrrolidine modulators of chemokine receptor activity

Charles Caldwell;Kevin T. Chapman;Jeffrey Hale;Dooseop Kim.
(2000)

189 Citations

Selective s1p1/edg1 receptor agonists

George A. Doherty;Michael J. Forrest;Richard Hajdu;Jeffrey J. Hale.
(2003)

182 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sander G. Mills

Hugh Rosen

Hugh Rosen

Scripps Research Institute

Publications: 33

Kevin R. Lynch

Kevin R. Lynch

University of Virginia

Publications: 25

Timothy L. Macdonald

Timothy L. Macdonald

University of Virginia

Publications: 24

Steven D. Douglas

Steven D. Douglas

Children's Hospital of Philadelphia

Publications: 19

Malcolm Maccoss

Malcolm Maccoss

MSD (United States)

Publications: 19

Volker Brinkmann

Volker Brinkmann

Novartis (Switzerland)

Publications: 18

Koji Uchida

Koji Uchida

University of Tokyo

Publications: 17

Graeme Milligan

Graeme Milligan

University of Glasgow

Publications: 15

Timothy Hla

Timothy Hla

Boston Children's Hospital

Publications: 15

Raymond Baker

Raymond Baker

MSD (United States)

Publications: 15

Trond Ulven

Trond Ulven

University of Copenhagen

Publications: 13

Marcus Lira Brandão

Marcus Lira Brandão

Universidade de São Paulo

Publications: 12

Klaus Lieb

Klaus Lieb

Johannes Gutenberg University of Mainz

Publications: 12

Charles B. Nemeroff

Charles B. Nemeroff

The University of Texas at Austin

Publications: 12

Tomas Hökfelt

Tomas Hökfelt

Karolinska Institute

Publications: 12

Pascal Furet

Pascal Furet

Novartis (Switzerland)

Publications: 11

Trending Scientists

Hongtao Lu

Hongtao Lu

Shanghai Jiao Tong University

Robert A. Greenes

Robert A. Greenes

Arizona State University

Vanessa Murdock

Vanessa Murdock

Amazon (United States)

Jing Jiang

Jing Jiang

Chongqing Jiaotong University

Claus Scheidereit

Claus Scheidereit

Max Delbrück Center for Molecular Medicine

Susan Povey

Susan Povey

University College London

John R. Bend

John R. Bend

University of Western Ontario

David H. Perlmutter

David H. Perlmutter

Washington University in St. Louis

Michel Brunet

Michel Brunet

University of Poitiers

Damir Brdjanovic

Damir Brdjanovic

IHE Delft Institute for Water Education

David F. Abbott

David F. Abbott

University of Melbourne

Cory M. Hogaboam

Cory M. Hogaboam

Cedars-Sinai Medical Center

Norman Segalowitz

Norman Segalowitz

Queensland University of Technology

William N. Rom

William N. Rom

New York University

José Manuel Fernández-Real

José Manuel Fernández-Real

University of Girona

Roger J. Hajjar

Roger J. Hajjar

Icahn School of Medicine at Mount Sinai

Something went wrong. Please try again later.